The Joint (JYNT)
(Delayed Data from NSDQ)
$11.08 USD
+0.03 (0.27%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $11.07 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.08 USD
+0.03 (0.27%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $11.07 -0.01 (-0.09%) 7:58 PM ET
3-Hold of 5 3
B Value D Growth D Momentum C VGM
Zacks News
The Joint Corp. (JYNT) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
The Joint Corp. (JYNT) closed the most recent trading day at $15.94, moving -1.48% from the previous trading session.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MGLN vs MOH: Which Health Insurance Stock is Placed Better?
by Zacks Equity Research
Molina Healthcare (MOH) and Magellan Health (MGLN) are poised to grow in the expanding health insurance industry. Here we try to figure out which stock is positioned better.
4 Stocks to Buy Despite Year-to-Date Fall in Health Insurance
by Sapna Bagaria
Despite regulatory noise, strong fundamentals and changing demographics of the country poise health insurance stocks for growth.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Why You Should Hold Tenet Healthcare (THC) in Your Portfolio
by Zacks Equity Research
Banking on a strong inorganic growth history and strategic divestitures, Tenet Healthcare (THC) holds immense potential to reap benefits for investors.
Why Should You Hold Centene (CNC) in Your Portfolio Now?
by Zacks Equity Research
Banking on a robust revenues and strategic initiatives, Centene (CNC) has immense potential to reap benefits for investors.
Why Should You Hold Anthem (ANTM) in Your Portfolio Now?
by Zacks Equity Research
Riding high on a solid revenue stream and a sturdy capital position, Anthem (ANTM) holds strong prospects to garner benefits for investors.
Joint, Cabot, Lowe's and Home Depot highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Joint, Cabot, Lowe's and Home Depot highlighted as Zacks Bull and Bear of the Day
Bull Of The Day: The Joint Corp (JYNT)
by Brian Bolan
This stock has a smoking chart, but it's not that type of "joint"
Why Should You Add WellCare Health (WCG) to Your Portfolio?
by Zacks Equity Research
Riding high on a solid revenue base and inorganic growth profile, WellCare Health (WCG) holds high potential to reap benefits for investors.
Why Adding HCA Healthcare to Your Portfolio Makes Sense
by Zacks Equity Research
Riding high on rising revenues and inorganic growth story, HCA Healthcare (HCA) looks promising enough to garner benefits for investors.
The Zacks Analyst Blog Highlights: SB One, Camden National, Middlesex Water, Joint and NexPoint Residential Trust
by Zacks Equity Research
The Zacks Analyst Blog Highlights: SB One, Camden National, Middlesex Water, Joint and NexPoint Residential Trust
Why You Should Hold Humana (HUM) Stock in Your Portfolio
by Zacks Equity Research
Humana (HUM) rides high on solid Medicare business growth and its strategic efforts. The stock holds immense potential to reap solid benefits for investors.
5 Top US-Focused Stocks to Buy as Trade Negotiations Stall
by Nalak Das
Trade-sensitive stocks, especially the ones that have large exposure to China or other international markets, lost a good chunk of value.
The Joint Corp. (JYNT) Is Up 9.28% in One Week: What You Should Know
by Zacks Equity Research
Does The Joint Corp. (JYNT) have what it takes to be a top stock pick for momentum investors? Let's find out.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
The Joint Corp. (JYNT) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
The Joint Corp. (JYNT) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH vs. JYNT: Which Stock Is the Better Value Option?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH or JYNT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH or JYNT: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
MOH vs. JYNT: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
MOH vs. JYNT: Which Stock Is the Better Value Option?
Zacks.com featured highlights include: TheStreet, Joint, Harvard Bioscience and CPI
by Zacks Equity Research
Zacks.com featured highlights include: TheStreet, Joint, Harvard Bioscience and CPI